|
| 36801962 | Prediction of whole body composition utilizing cross-sectional abdominal imaging in pediatrics. | | 2023 |
| 37885599 | Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience. | Paediatr Child Health | 2023 |
| 36897253 | Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma. | | 2023 |
| 37016844 | Whole genome transcriptome analysis in a case of a neonatal soft tissue sarcoma with YWHAE:NUTM2B fusion. | Pediatr Blood Cancer | 2023 |
| 37460202 | Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes. | J Med Genet | 2023 |
| 37382186 | Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial. | Cancer | 2023 |
| 37126021 | Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. | Clin Cancer Res | 2023 |
| 34612613 | Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease? | Cancer Rep (Hoboken) | 2022 |
| 36358729 | Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer. | Cancers | 2022 |
| 35740650 | Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial. | Cancers (Basel) | 2022 |
| 34455698 | Diagnostic and treatment intervals are not associated with survival in rhabdomyosarcoma: A Cancer in Young People in Canada study. | Pediatr Blood Cancer | 2022 |
| 34411405 | Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. | Pediatric Blood and Cancer | 2021 |
| 33523537 | Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N-activating mutation. | Pediatr Blood Cancer | 2021 |
| 34213775 | Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma. | International Journal of Cancer | 2021 |
| 33768871 | NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling. | Clin Case Rep | 2021 |
| 33864908 | Life-Threatening Intratumoral Hemorrhage in an Infant with Hepatoblastoma Successfully Treated with Hepatic Arterial Embolization. | Journal of Vascular and Interventional Radiology | 2021 |
| 33273412 | Parent Perspectives on Information-seeking, Trustworthiness, and Decision-making in High-risk Neuroblastoma. | J Pediatr Hematol Oncol | 2021 |
| 33435412 | Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients. | Curr Oncol | 2021 |
| 34617981 | Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. | JAMA Oncol | 2021 |
| 34931022 | Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury. | NPJ Precis Oncol | 2021 |
| 31259825 | The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD. | Journal of Pediatric Hematology/Oncology | 2020 |
| 31925920 | Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma. | Pediatric Blood and Cancer | 2020 |
| 33134827 | Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology. | JNCI Cancer Spectr | 2020 |
| 32724107 | Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. | Sci Rep | 2020 |
| 30666782 | Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission. | Pediatr Blood Cancer | 2019 |
| 31651965 | Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer. | JAMA Netw Open | 2019 |
| 35100702 | Therapeutic Implication of Genomic Landscape of Adult Metastatic Sarcoma. | JCO Precis Oncol | 2019 |
| 30393943 | Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. | Pediatr Blood Cancer | 2019 |
| 31122568 | ALK-Positive Lung Adenocarcinoma Arising in an Adolescent Treated for Relapsed Neuroblastoma. | J Thorac Oncol | 2019 |
| 30786157 | Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors. | Pediatric Blood and Cancer | 2019 |
| 31372595 | Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer. | JCO Precis Oncol | 2018 |
| 29610391 | Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma. | Cold Spring Harb Mol Case Stud | 2018 |
| 30976750 | Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies. | JNCI Cancer Spectr | 2018 |
| 27841828 | Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma. | Journal of Pediatric Hematology/Oncology | 2017 |
| 28544814 | Optimization of liposomal topotecan for use in treating neuroblastoma. | Cancer Medicine | 2017 |
| 28327925 | ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma. | Annals of Oncology | 2017 |
| 28874686 | Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits. | Sci Rep | 2017 |
| 27259007 | ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. | Am J Surg Pathol | 2016 |
| 27148575 | Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. | Cold Spring Harb Mol Case Stud | 2015 |
| 25263424 | Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children. | Pediatric Blood and Cancer | 2015 |
| 24236830 | Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia. | British Journal of Haematology | 2014 |
| 24357155 | Antidepressant use among survivors of childhood, adolescent, and young adult cancer: letter to the editor response. | Pediatric Blood and Cancer | 2014 |
| 24038992 | Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project. | Pediatr Blood Cancer | 2014 |
| 23281214 | Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. | Pediatr Blood Cancer | 2013 |
| 21707222 | Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia. | Pediatric Hematology and Oncology | 2011 |
| 21504710 | Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. | Cancer genetics | 2011 |
| 21632841 | Costs and consequences of immunosuppressive therapy in children with aplastic anemia. | Haematologica | 2011 |
| 16462584 | Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville. | Journal of Pediatric Hematology/Oncology | 2006 |